Oxford provides services across the globe. If you need more information, please contact us.
A large pharmaceutical organization formed a new device-manufacturing division and requested Oxford’s support in achieving compliance for a brand new range of combination products. The scope of the project required a large group of consultants to assist the client with preparing new product lines to be compliant with ISO 13485, ISO 14971, and 21 CFR Part 820. Several project leaders were also required to manage the development of more than 50 products within their portfolio of drug-delivery services. Our client needed the right partner to help accelerate the development lifecycle and get their products to market more quickly.
Through a careful vetting process, Oxford placed over 40 senior-level consultants, each holding a minimum of seven to eight years of experience, with knowledge in both pharmaceuticals and medical devices. We provided experts with an in-depth understanding of medical device compliance, and the ability to execute a hands-on approach to meet project deliverables. Our team supported the development of various combination products, including: pre-filled syringes, autoinjectors, subcutaneous patches, pumps, dry powder and metered dose inhalers.
Project workstreams covered:
All project goals and requirements were successfully reached. Over a four-year period, our client retained all 40 consultants. The consultant team was so effective that each person received a six or 12-month expansion on their contract. Working in close collaboration, we helped qualify and deliver 50 new combination products to market within two to three years.
By evaluating requirements, providing the right high quality candidates, and maintaining ongoing communication throughout the project, Oxford became a preferred partner, with multiple consultants actively supporting new and ongoing objectives within this device-manufacturing business unit.